Why the study?
Does daily low-dose aspirin prevent morbidity and mortality from preeclampsia?
Does daily low-dose aspirin prevent morbidity and mortality from preeclampsia?
Daily low-dose aspirin starting in the second trimester prevents clinically important health outcomes related to preeclampsia without identified harms.
Supports low-dose aspirin from the second trimester in at-risk pregnancies; confirms benefit without harms in Level 1 evidence.
Daily low-dose aspirin beginning as early as the second trimester prevented clinically important health outcomes. No harms were identified, but long-term evidence was limited.
No takes yet. Share an insight, caveat, or question.
Henderson et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: